CFRX Company Profile and Key Details
ContraFect Corporation
CFRX Stock Price Chart
Stock Price Today
ContraFect Corporation (CFRX) stock declined over -27.95%, trading at $0.05 on NASDAQ, down from the previous close of $0.07. The stock opened at $0.06, fluctuating between $0.05 and $0.06 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis; and CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also initiated an expanded access program to provide Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.
Company Information
| Employees | 23 |
| Beta | 0.29 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
ContraFect Corporation (NASDAQ: CFRX) stock price is $0.05 in the last trading session. During the trading session, CFRX stock reached the peak price of $0.06 while $0.05 was the lowest point it dropped to. The percentage change in CFRX stock occurred in the recent session was -27.95% while the dollar amount for the price change in CFRX stock was -$0.02.
The NASDAQ listed CFRX is part of Biotechnology industry that operates in the broader Healthcare sector. ContraFect Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Ms. Natalie Bogdanos J.D.
Gen. Counsel, Corporation Sec. & Data Protection Officer
Dr. Roger James Pomerantz F.A.C.P., FACP, M.D.
Chairman, Chief Executive Officer & Pres
Mr. Michael Messinger CPA, CPA
Chief Financial Officer
Mr. Matthew Salamone P.H.R., SPHR
Vice President of HR
Dr. Gary Woodnutt
Senior Vice President of Translational Sciences & Preclinical Devel.
CFRX's closing price is 100% higher than its 52-week low of $0.03 where as its distance from 52-week high of $9.62 is -99.48%.
Number of CFRX employees currently stands at 23.
Official Website of CFRX is: https://www.contrafect.com
CFRX could be contacted at phone 914 207 2300 and can also be accessed through its website. CFRX operates from 28 Wells Avenue, Yonkers, NY 10701, United States.
CFRX stock volume for the day was 910.22K shares. The average number of CFRX shares traded daily for last 3 months was 262.78K.
The market value of CFRX currently stands at $0.00 with its latest stock price at $0.05 and 0 of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com